Most Read Articles
23 Apr 2018
Long‐term treatment with perampanel in the adjunctive setting appears to provide improved seizure control without raising new safety/tolerability signals in patients with epilepsy, particularly those with secondarily generalized seizures at baseline, according to the results of an open-label extension of phase III trials.
Audrey Abella, 20 Mar 2020
The addition of highly purified cannabidiol (CBD) into an antiepileptic regimen led to reductions in convulsive seizure rates in children with Dravet syndrome (DS), the GWPCARE2* study has shown.
27 May 2020
High rather than low levels of neonatal 25(OH)D3 pose an increased risk of incident epilepsy in early childhood, a finding that may be attributed to chance, confounding, or late gestational vitamin D exposure, according to a study.
Jairia Dela Cruz, 29 Jan 2020
In the treatment of idiopathic generalized epilepsy, switching from valproate to other antiepileptic drugs due to potential childbearing issues may prove detrimental, heightening the risk of poor seizure control, as shown in a recent study.

Barriers to healthcare up risk of chronic pain

26 Jul 2020

Social and environmental factors, particularly those related to access to healthcare, affect the risk of chronic pain among adolescents, a recent study has shown.

Researchers retrieved data from the Add Health Study, a longitudinal and nationally-representative public health survey of adolescents across the US. A total of 6,505 adolescents (mean age, 14.87±1.73 years; 51.6 percent female) were enrolled at baseline and were followed for three waves. Variables of interest included chronic pain, household income, and health insurance, among others.

Nearly a quarter (21.8 percent) of the participants reported chronic pain. This was more common in females than in males (25.5 percent vs 18.0 percent; p<0.001), and in Native American youth (32.1 percent). Most of the participants (56 percent) had private insurance, while only 32 percent had public health insurance plans; 12 percent had no insurance.

In the overall sample, being female (odds ratio [OR], 1.61, 95 percent confidence interval [CI], 1.30–1.99; p<0.001) was a significant risk factor for chronic pain. The same was true for experiencing violence (OR, 1.07, 95 percent CI, 1.01–1.14; p<0.05) and feeling unsafe in their environment (OR, 1.08, 95 percent CI, 1.03–1.13; p<0.01).

Notably, having barriers to healthcare also emerged as a significant risk factor for chronic pain (OR, 1.25, 95 percent CI, 1.19–1.31; p<0.001). This remained a significant risk factor in both White and Black youth.

The said barriers included having no means to travel to a care centre, having no one to go along with them, experiencing difficulties in making appointment, fear of the doctor and medical advice, and inability to pay for care.

Editor's Recommendations
Most Read Articles
23 Apr 2018
Long‐term treatment with perampanel in the adjunctive setting appears to provide improved seizure control without raising new safety/tolerability signals in patients with epilepsy, particularly those with secondarily generalized seizures at baseline, according to the results of an open-label extension of phase III trials.
Audrey Abella, 20 Mar 2020
The addition of highly purified cannabidiol (CBD) into an antiepileptic regimen led to reductions in convulsive seizure rates in children with Dravet syndrome (DS), the GWPCARE2* study has shown.
27 May 2020
High rather than low levels of neonatal 25(OH)D3 pose an increased risk of incident epilepsy in early childhood, a finding that may be attributed to chance, confounding, or late gestational vitamin D exposure, according to a study.
Jairia Dela Cruz, 29 Jan 2020
In the treatment of idiopathic generalized epilepsy, switching from valproate to other antiepileptic drugs due to potential childbearing issues may prove detrimental, heightening the risk of poor seizure control, as shown in a recent study.